tessa therapeutics
Tessa Therapeutics Raises US$80 Million In Funding
Proceeds from the latest funding round will be used to further develop Tessa’s solid tumor immunotherapy pipeline.
When T Spells Trouble For Cancer
The world’s largest clinical trial of T-cells for cancer is being conducted by a Singapore-based biotech company, Tessa Therapeutics. Sim Shuzhen finds out more.
10 Of Singapore’s Hottest Biotech Startups
Check out these ten biomedical startups leading healthcare innovation from the little red dot.
Tessa Therapeutics Completes Acquisition of Euchloe Bio
Tessa Therapeutics has fully acquired Euchloe Bio, a biotech company focused on developing and commercializing therapeutic antibodies.
